NICE - Endorsed Clinical Guidelines 2013/2014
It is important to note that the advice contained within the guidance does not override or replace the individual responsibility of health professionals to make appropriate decisions in the circumstances of their individual patients, in consultation with the patient and/or guardian or carer. This would, for example, include situations where individual patients have other conditions or complications that need to be taken into account in determining whether the NICE guidance is fully appropriate in their case.
The following clinical guidelines have been endorsed during 2013-14 using the process
Clinical Guidelines
March 2014
NICE Clinical Guideline CG 176 - Head injury: Triage, assessment, investigation and early management of head injury in children, young people and adults - HSC (SQSD) (NICE CG176) 6/14
- Note this guidance has been updated and replaced by NG232 - Head injury: assessment and early management, endorsed by the DoH in August 2023.
February 2014
NICE Clinical Guideline CG 175 - Prostate cancer: diagnosis and treatment - HSC (SQSD) (NICE CG175) 3/14
- This guidance has been updated and replaced by NICE Clinical Guideline NG131 - Prostate cancer: diagnosis and management, which was endorsed by the DoH in July 2019.
January 2014
NICE Clinical Guideline CG 172 - Myocardial Infarction Secondary Prevention - HSC (SQSD) (NICE CG172) 1/14 - ‘Note this guidance has been updated and replaced by NICE Clinical Guideline NG185 - Acute coronary syndromes, which was endorsed by the DoH in September 2021.
NICE Clinical Guideline CG 173 - Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings - HSC (SQSD) (NICE CG173) 2/14
- Note this updates and replaces CG 96
- In December 2014, NICE issued an amendment to the footnote for recommendation 1.1.8 which advises that "the Lyrica (Pfizer) brand of pregabalin has patent protection until July 2017 for its licensed indication of treatment of peripheral and central neuropathic pain; until such time as this patent expires generic pregabalin products will not be licensed for this indication and their use for this condition would be off-label and may infringe the patent.”
- Generic pregabalin must not be used for the treatment of neuropathic pain.
- In December 2014, NICE issued an amendment to the footnote for recommendation 1.1.8 which advises that "the Lyrica (Pfizer) brand of pregabalin has patent protection until July 2017 for its licensed indication of treatment of peripheral and central neuropathic pain; until such time as this patent expires generic pregabalin products will not be licensed for this indication and their use for this condition would be off-label and may infringe the patent.”
The following clinical guidelines have been endorsed during 2013-14 using the process that came into effect on 28 September 2011.
Fully Endorsed
(Please also refer to Endorsed with Caveats section to see all guidance endorsed by DoH)
September 2013
August 2013
- NICE Clinical Guideline CG 161 - The assessment and prevention of falls in older people Note this guidance has been updated and replaced by NG249 - Falls: assessment and prevention in older people and in people 50 and over at higher risk, endorsed by the DoH in August 2025
- NICE Clinical Guideline CG 167 - Myocardial Infarction with ST-segment elevation (STEMI) - ‘Note this guidance has been updated and replaced by NICE Clinical Guideline NG185 - Acute coronary syndromes, which was endorsed by the DoH in September 2021.
July 2013
NICE Clinical Guideline CG 160 - Feverish illness in children
- This guidance has been updated and replaced by NICE Clinical Guideline NG143 - Fever in under 5s: assessment and initial management, which was endorsed by the DoH in January 2020.
Endorsed with Caveats
Clinical guidelines frequently make reference to specific legislation and guidance that do not apply in Northern Ireland. All clinical guidelines should be read taking these differences into consideration. These caveats can be found in the document NICE Clinical Guideline caveats
November 2013
- Additional Caveats
- NICE have published an evidence update which focuses on a summary of selected new evidence relevant to NICE guideline CG156. NICE Evidence updates help to reduce the need for individuals, managers and commissioners to search for new evidence and keep health and social care professionals up-to-date with new research. While Evidence Updates do not replace current accredited guidance and do not provide formal recommendations, they do highlight new evidence that health and social care professionals may wish to consider alongside current guidance.
- This guidance has been partially updated by NICE Clinical Guideline NG73 - Endometriosis: diagnosis and management, which was endorsed by the DoH in October 2017.
October 2013
NICE Clinical Guideline - CG 169 - Acute Lidney Injury
- This guidance has been updated and replaced by NICE Clinical Guideline NG148 - Acute kidney injury: prevention, detection and management, which was endorsed by the DoH in February 2020.
NICE Clinical Guideline CG 170 - Autism - management of autism in children and young people
NICE Clinical Guideline CG 171 - Urinary incontinence in women
August 2013
NICE Clinical Guideline CG 155 - Psychosis and schizophrenia in children and young people
- Additional Caveats
- NICE have published an evidence update which focuses on a summary of selected new evidence relevant to NICE guideline CG155. NICE Evidence updates help to reduce the need for individuals, managers and commissioners to search for new evidence and keep health and social care professionals up-to-date with new research. While Evidence Updates do not replace current accredited guidance and do not provide formal recommendations, they do highlight new evidence that health and social care professionals may wish to consider alongside current guidance.
NICE Clinical Guideline CG 162 - Stroke rehabilitation
Note this guidance has been updated and replaced by NG236 - Stroke rehabilitation in adults, endorsed by the DoH in February 2024
NICE Clinical Guideline CG 163 - Idiopathic pulmonary fibrosis
NICE Clinical Guideline CG 164 - Familial breast cancer
NICE Clinical Guideline CG 166 - Ulcerative colitis: management in adults, children and young people.
- This guidance has been updated and replaced by NICE Clinical Guideline NG130 - Ulcerative colitis: management, which was endorsed by the DoH in June 2019.
July 2013
NICE Clinical Guideline CG 159 - Social Anxiety Disorder
May 2013
NICE Clinical Guideline CG 129 - Multiple Pregnancy
- This guidance has been updated and replaced by NICE Clinical Guideline NG137 - Twin and triplet pregnancy, which was endorsed by the DoH in November
NICE Clinical Guideline CG 157 - Hyperphosphataemia in chronic kidney disease - ‘Note this guidance has been updated and replaced by NICE Clinical Guideline NG203 - Chronic kidney disease: assessment and management, which was endorsed by the DoH in November 2021.
NICE Clinical Guideline CG 158 - Conduct disorders in children and young people
Not Endorsed as Applicable to Northern Ireland
None